12/23
01:23 pm
trvi
MarketBeat's Top 5 Rated Small-Cap Stocks [Yahoo! Finance]
Low
Report
MarketBeat's Top 5 Rated Small-Cap Stocks [Yahoo! Finance]
12/21
07:42 am
trvi
Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change [Yahoo! Finance]
Medium
Report
Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change [Yahoo! Finance]
12/19
10:04 am
trvi
Trevi Therapeutics (NASDAQ:TRVI) was given a new $18.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
Trevi Therapeutics (NASDAQ:TRVI) was given a new $18.00 price target on by analysts at Stifel Nicolaus.
12/4
07:30 am
trvi
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
Low
Report
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
11/21
05:31 am
trvi
Trevi Therapeutics (NASDAQ:TRVI) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Medium
Report
Trevi Therapeutics (NASDAQ:TRVI) was upgraded by analysts at B. Riley to a "strong-buy" rating.
11/19
06:02 am
trvi
Trevi Therapeutics (NASDAQ:TRVI) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Medium
Report
Trevi Therapeutics (NASDAQ:TRVI) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
11/17
08:45 am
trvi
Trevi Therapeutics: Big Cough Data, Bigger Execution Risk [Seeking Alpha]
Low
Report
Trevi Therapeutics: Big Cough Data, Bigger Execution Risk [Seeking Alpha]
11/15
07:05 pm
trvi
How Trevi Therapeutics' (TRVI) Phase 3 Progress and Fresh Funding May Influence Investor Expectations [Yahoo! Finance]
Low
Report
How Trevi Therapeutics' (TRVI) Phase 3 Progress and Fresh Funding May Influence Investor Expectations [Yahoo! Finance]
11/15
04:40 am
trvi
Trevi Therapeutics (TRVI): Assessing Valuation After Clinical Program Advances and Cash Runway Extension [Yahoo! Finance]
Low
Report
Trevi Therapeutics (TRVI): Assessing Valuation After Clinical Program Advances and Cash Runway Extension [Yahoo! Finance]
11/14
04:18 pm
trvi
Trevi Therapeutics (NASDAQ:TRVI) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $19.00 price target on the stock.
Low
Report
Trevi Therapeutics (NASDAQ:TRVI) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $19.00 price target on the stock.
11/14
09:14 am
trvi
Trevi Therapeutics (NASDAQ:TRVI) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Trevi Therapeutics (NASDAQ:TRVI) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
11/14
09:05 am
trvi
Trevi Therapeutics (NASDAQ:TRVI) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Trevi Therapeutics (NASDAQ:TRVI) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
11/13
09:53 am
trvi
Trevi Therapeutics (NASDAQ:TRVI) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $13.00 price target on the stock.
Medium
Report
Trevi Therapeutics (NASDAQ:TRVI) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $13.00 price target on the stock.
11/6
04:36 pm
trvi
Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025 [Yahoo! Finance]
Low
Report
Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025 [Yahoo! Finance]
11/6
04:05 pm
trvi
Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025
Neutral
Report
Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025
11/4
07:30 am
trvi
Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference
Low
Report
Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference
10/8
07:51 am
trvi
Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting [Yahoo! Finance]
Low
Report
Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting [Yahoo! Finance]
10/8
07:30 am
trvi
Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting
Low
Report
Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting